French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析

◆英語タイトル:French National Institute of Health and Medical Research - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011679
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, health technologies, metabolism, cell biology and immunology, among others. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM also conducts translational research and development services. It operates research units and research centers. INSERM is headquartered in Paris, France.

French National Institute of Health and Medical Research – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2011 to YTD 2017 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
French National Institute of Health and Medical Research, Medical Equipment, Deal Details 11
Partnerships 11
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 11
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 12
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 13
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 14
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 16
Dassault Systemes Enters into Agreement with Inserm Transfert 17
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 18
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 19
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 20
Inserm Transfert Enters into Licensing Agreement with HalioDx 21
French National Institute of Health and Medical Research – Key Competitors 22
French National Institute of Health and Medical Research – Key Employees 23
French National Institute of Health and Medical Research – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Affiliate 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
French National Institute of Health and Medical Research, Medical Equipment, Key Facts 2
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2011 to YTD 2017 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Deals By Market, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 11
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 12
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 13
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 14
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 16
Dassault Systemes Enters into Agreement with Inserm Transfert 17
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 18
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 19
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 20
Inserm Transfert Enters into Licensing Agreement with HalioDx 21
French National Institute of Health and Medical Research, Key Competitors 22
French National Institute of Health and Medical Research, Key Employees 23
French National Institute of Health and Medical Research, Subsidiaries 24
French National Institute of Health and Medical Research, Affiliate 24

★海外企業調査レポート[French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sacyr, S.A. (formerly Sacyr Vallehermoso S.A.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sacyr, S.A. (formerly Sacyr Val …
  • Virgin Islands Water and Power Authority:企業の戦略的SWOT分析
    Summary Virgin Islands Water and Power Authority (WAPA) is a not-for profit public autonomous public electric utility, operating under Government of the Virgin Islands. The authority generates and distributes electricity as well supplies water. It owns and operates fuel oil fired power plants namely …
  • Phillips-Medisize Corp:企業のM&A・提携動向(医療機器分野)
    Summary Phillips-Medisize Corp (Phillips-Medisize), is a provider of outsourced design and manufacturing services to medical, defense, consumer, and automotive markets. It offers a broad range of pre-production and production services. The company offers a range of drug delivery, medical device and …
  • NK Minda Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NK Minda Group Mergers and Acqu …
  • Plastika Kritis S.A. (PLAKR):企業の財務及び戦略的SWOT分析
    Summary Plastika Kritis S.A. (Plastika), formerly Crete Plastics S.A. is a chemical company that provides plastic packaging solutions. The company's products include masterbatches and compounds, multilayer plastic films for agricultural applications, geomembranes, polyethylene pipes and recycled pla …
  • Benesse Holdings, Inc. (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings, Inc. (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Shandong Liaherd Chemical Industry Co., Ltd. (002217):企業概要、財務及び戦略的SWOT分析
    Summary Shandong Liaherd Chemical Industry Co., Ltd (Shandong Liaherd) is a chemical company. The company manufactures non-organic chemical products and chemical fertilizers. Its products include melamine, ammonium nitrate, industrial sodium nitrate, compound fertilizer, chloride, industrial sodium, …
  • Home Federal Bancorp, Inc. (HFBL):企業概要、財務及び戦略的SWOT分析
    Summary Home Federal Bancorp, Inc. of Louisiana (Federal Bank) is a financial service provider, based in the US. The bank provides financial options to individuals. It provides different types of accounts and services to meet all the financial needs of individuals. Federal Bank offers Personal Banki …
  • Northbrook Energy, LLC:企業のM&A・提携動向(エネルギー分野)
    Summary Northbrook Energy, LLC (Northbrook Energy) is a power producer that develops, owns and operates hydroelectric assets in North America. The company provides services such as asset management services, operations and maintenance services and general and administrative services. Its power plant …
  • Genentech Inc – Product Pipeline Analysis, 2016 Update
    Summary Genentech Inc (Genentech) is a biotech company that undertakes discovery, development, manufacture and commercialization of medicines for the treatment of patients with serious medical conditions. The company focuses on developing drugs for unmet medical needs in the areas of oncology, immun …
  • GeoBio Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GeoBio Energy, Inc. Mergers and …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務分析
    SummaryTIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • Saibu Gas Co., Ltd. (9536):企業財務及び戦略的SWOT分析
    Summary Saibu Gas Co., Ltd. (Saibu Gas) is an oil and gas company that offers production, distribution, supply and sale of natural gas. The company produces, sells and installs gas equipment and apparatus, and related construction work. Its activities include heat service business, sale of LNG and u …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    SummaryAllscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • NorthWestern Corporation:企業の戦略・SWOT・財務分析
    SummaryNorthWestern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Ganesh Benzoplast Ltd. (500153):企業概要、財務及び戦略的SWOT分析
    Summary Ganesh Benzoplast Ltd. (GBL) is a pharmaceutical and chemical company. The company operates in manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants additives and API/bulk drug. Its food preservatives include …
  • Faith, Inc. (4295):企業財務及び戦略的SWOT分析
    Summary Faith, Inc. (Faith) is a technology service provider that offers solutions from music and video production and distribution system construction. The company offers services in the areas of music communication, entertainment communication, educational communication and life communication. It …
  • AdvanDx Inc:企業のM&A・提携動向(医療機器分野)
    Summary AdvanDx Inc (AdvanDx) is a biotech company that offers healthcare solutions. The company provides rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. It operates in the molecular testing of positive blood culture …
  • Kiadis Pharma NV (KDS):企業財務及び戦略的SWOT分析
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that researches, develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 offe …
  • Rolfes Holdings Limited (RLF):企業の財務及び戦略的SWOT分析
    Summary Rolfes Holdings Limited (Rolfes), formerly Rolfes Technology Holdings Limited, is a chemical company that operates through industrial chemicals, agricultural chemicals, and mining and water chemical divisions. The company’s industrial chemicals division offers products such as alkyd resins, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆